Last week, Philips sent two big news in a row. On June 28, Philips acquired Spectranetics for a total price of 1.9 billion euros ($2.16 billion). The transaction is expected to be completed in the third quarter of this year. On the 29th, Dow Jones News announced that Philips has announced the acquisition of CardioProlific. Disclosure of relevant financial data.
68% of Spectranetics' business is cardiovascular intervention, which can produce image-guided treatment devices for the treatment of heart and peripheral vascular disease. CardioProlific is also a company that performs peripheral vascular interventions. Although it is small, its peripheral vascular thrombectomy technology will Enhance Philips treatment options.
Philips Healthcare is the largest business unit, following last year stripped the lighting business, Philips is further increased investment in health care.
The acquisition is another big move for the treatment business after the completion of Volcano's acquisition in 2015, which will further strengthen Philips' image-guided treatment business.
As the field of diagnostic imaging has gradually become the "Red Sea", the field of imaging therapy has recently grown very rapidly and has considerable benefits. Especially in the field of cardiac therapy, the cardiology market is getting stronger as people pay more attention to cardiovascular diseases. C-arm diagnostic equipment combined with cardiovascular therapy, such diagnosis + treatment will be a very promising overall solution.
It is foreseeable that the cardiovascular diagnosis and treatment market will become a new blue ocean in the field of imaging.
Philips Imaging Interventional Therapy
At present, the cardiovascular digital angiography market is almost the world of GPS.
Although Shimadzu, Toshiba and other Japanese vascular machines have had a heyday, they were quickly surpassed by GPS, both in the global market and in the Chinese market.
Siemens was the first to enter the Chinese market in GPS. After Philips came, it began to share with Siemens. Although GE entered the Chinese market at the latest, the strategy of quickly grabbing the market once led the market share, but was later Philips gave the go.
China Extract Powder For Use As Dietary Supplement Extract Powder, Extract Powder Manufacturer
Shaanxi Kang New Pharmaceutical co., Ltd. , https://www.apipepdites.com